Sector valuations GC Genome Corporation
Stocks
A340450
KR7340450006
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,465.00 KRW | +0.34% |
|
-8.13% | -34.53% |
| Dec. 09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.18x | - | 11.46x | - | 70.48M | ||
| -163.8x | 20.91x | -17.05x | 13.61x | -185.56x | -149.82x | -.--% | 39.08B | ||
| 19.09x | 2.41x | 0.49x | 1.86x | 10.69x | 12.63x | 1.05% | 22.69B | ||
| 16.77x | 1.19x | 0.99x | 1.32x | 7.48x | 13.66x | 5.19% | 7.17B | ||
| 324.67x | - | -1.82x | - | - | - | - | 4.98B | ||
| 48.95x | 10.18x | 3.07x | 8.71x | 30.94x | 38.62x | 1.06% | 3.01B | ||
| -19.09x | - | -0.05x | - | - | - | - | 1.9B | ||
| 31.71x | 1.86x | 0.04x | 1.13x | 9.45x | 13.79x | 0.8% | 1.82B | ||
| -31.66x | - | 0.67x | - | - | - | -.--% | 1.84B | ||
| 12.7x | 1.69x | 0.94x | 1.32x | 5.17x | 8.83x | 5.96% | 1.71B | ||
| 35.37x | 1.72x | -0.12x | 1.56x | 12.71x | 21.69x | 1.52% | 1.76B | ||
| 83.41x | 14.99x | 4.25x | 17.38x | 42.9x | 58.49x | 0.12% | 1.49B | ||
| 58.5x | 8.06x | 1.57x | 7x | 28.9x | 41.78x | 0.36% | 1.22B | ||
| 32.52x | 1.37x | -2.11x | 0.8x | 6.62x | 22.66x | 3.74% | 1.13B | ||
| -4.06x | 0.53x | -4.07x | 1x | - | -2.54x | - | 929M | ||
| 41.39x | 12.73x | 2.02x | - | - | - | 2.11% | 849M | ||
| 18.09x | 1.04x | -14.22x | - | - | - | 3.44% | 839M | ||
| 24.89x | 1.87x | 0.97x | - | - | - | 0.39% | 766M | ||
| -45.32x | - | 1.52x | 192.45x | -41.98x | -39.86x | - | 626M | ||
| Average | 26.90x | 5.75x | -1.27x | 19.18x | -6.61x | 3.95x | 1.84% | 4.94B | |
| Weighted average by Cap. | -40.15x | 11.45x | -6.95x | 9.35x | -82.39x | -62.11x | 1.04% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















